Dietary influence on physical functioning in the Women’s Health Initiative (WHI) randomized Dietary Modification (DM) trial.

Authors

null

Rowan T. Chlebowski

Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance,, Duarte, CA

Rowan T. Chlebowski , Aaron K. Aragaki , Kathy Pan , Rebecca A. Nelson , Ana Barac , JoAnn E Manson , Marcia L. Stefanick , Farha Ikramuddin , Karen Johnson , Jessica L. Krok-Schoen , Deepika Laddu , Margaret S. Pichardo , Linda Snetselaar , Meryl LeBoff , Yvonne Michael

Organizations

Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance,, Duarte, CA, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, CA, City of Hope, Duarte, CA, MedStar Heart and Vascular Institute, Washington, DC, Brigham and Women's Hospital/Harvard Medical School, Boston, MA, Stanford Prevention Research Center, Stanford, CA, University of Minnesota, Minneapolis, MN, University of Tennessee Health Science Center, Memphis, TN, Division of Medical Dietetics and Health Sciences, School of Health and Rehabilitation Sciences, The Ohio State University, Columbus, OH, University of Illinois Chicago College of Applied Health Sciences, Chicago, IL, Yale University, New Haven, CT, University of Iowa, Iowa City, IA, Brigham and Women's Hospital, Boston, MA, Drexel University, Philadelphia, PA

Research Funding

U.S. National Institutes of Health

Background: In the WHI DM randomized trial, randomization to the dietary intervention group was associated with a 21% lower breast cancer mortality (P = 0.02) (JCO 2020), and while not an intervention target, with higher physical activity as well. Therefore, we examined whether these lifestyle changes attenuate age-related physical functioning decline. Methods: From 1993-1998, 48,835 postmenopausal women, aged 50-79 years, were randomized to dietary intervention or usual diet comparison groups through 8 years intervention and 19 years cumulative follow-up. Breast cancer findings, as primary outcome, have been reported. Physical functioning was assessed using the RAND 36-Item Short Form Health Survey (SF-36), which assessed limitations of 10 hierarchical physical activities, scored from 0 to 100, with a higher score indicating less limited physical function. The trajectory of longitudinal physical functioning was the primary study outcome, assessed by comparing findings in the two randomization groups, overall, and by baseline physical activity and age decade. Additionally, findings were reported against a disability threshold (when assistance in daily activities is required). Results: Physical functioning was assessed nearly half a million times during the study (n = 495,317) with 11.0 (median) assessments per participant. Physical functioning score was significantly better in the intervention versus comparison groups during the 8-year intervention and extended follow-up through 12 years (median) (P = 0.001), representing a reduction in age-related functional decline. The intervention effect subsequently lost significance at 19 years and both randomization groups crossed the disability threshold at similar times. Differences between randomization groups in physical functioning emerged after stratification by physical activity and age decade (P-interaction = 0.007). Among all participants physically active at entry, the intervention initially had a statistically significant, favorable influence on physical functioning which attenuated post-intervention. In contrast, among younger, physically inactive women 50-59 years of age, the intervention had a persistent, statistically significant, favorable influence on physical functioning with associated delay in crossing the disability threshold. Conclusions: In the primary prevention setting of the WHI DM randomized trial, with long-term follow-up, a dietary intervention which has been shown to reduce breast cancer mortality also significantly reduced age-related functional decline through 12 years. Among all participants, the intervention effect was attenuated with longer follow-up. However, reduction in age-related functional decline was sustained in younger women in the intervention group who were inactive at entry, a potential target population for future behavior interventions. Clinical trial information: NCT00000611.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Prevention, Risk Reduction, and Hereditary Cancer

Track

Prevention, Risk Reduction, and Genetics

Sub Track

Cancer Prevention

Clinical Trial Registration Number

NCT00000611

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr 10552)

DOI

10.1200/JCO.2022.40.16_suppl.10552

Abstract #

10552

Poster Bd #

428

Abstract Disclosures

Similar Abstracts

Abstract

2023 ASCO Annual Meeting

Circulating methylated-HOXA9 tumor DNA as a biomarker for mortality in recurrent breast cancer.

First Author: Torben Hansen

First Author: Rowan T. Chlebowski

Abstract

2022 ASCO Quality Care Symposium

Association of disability with long-term noncompliance of breast cancer screening.

First Author: Hyo Jung Tak